Transdermal innovations in diabetes management

Diabetes mellitus, an endocrine disorder affecting glucose metabolism, has been crippling mankind for the past two centuries. Despite the advancements in the understanding pertaining to its pathogenesis and treatment, the currently available therapeutic options are far from satisfactory. The growing diabetic population increases the gravity of the situation. The shortcomings of the conventional drug delivery systems necessitate the need to delve into other routes. On account of its merits over other routes, the transdermal approach has drawn the interest of the researchers around the world. The transdermal drug delivery systems are aimed to achieve therapeutic concentrations of the drug through skin. These systems are designed so that the drug can be delivered at a pre-determined and controlled rate. This makes it particularly conducive to treat chronic disorders like diabetes. Correspondingly, the adverse effects and inconvenience concomitant with oral and parentral route are circumvented. This article attempts to outline the development of transdermal drug delivery systems to optimize diabetes pharmacotherapy. It not only covers the transdermal approaches adopted to fine-tune insulin delivery, but also, discusses various transdermal drug delivery systems fabricated to improve the therapeutic performance of oral hypoglycaemic agents. Such formulations include the advanced drug delivery systems, namely, transferosomal gels, microemulsions, self-dissolving micropiles, nanoparticles, insulin pumps, biphasic lipid systems, calcium carbonate nanoparticles, lecithin nanoparticles; physical techniques such as iontophoresis and microneedles and, drugs formulated as transdermal patches. In addition to this, the authors have also shed light on the future prospects and patented and commercial formulations of antidiabetic agents.

The "Prince of Medicine": Yūhannā ibn Māsawayh and the foundations of the western pharmaceutical tradition

This essay examines three medieval pharmaceutical treatises purportedly authored by Yūhannā ibn Māsawayh (anglicized to John Mesue) and traces their immense influence on the development of pharmacy in early modem Europe and the Hispanic world. Despite the importance of these works throughout the early modern period, Mesue is relatively unknown in the history of pharmacy and medicine, and his exact identity remains unclear. This essay argues that "Mesue" was most likely a pseudonym used by an unknown author of the Latin West and that the three works were crafted to meet the demands of the developing "medical marketplace" of late thirteenth-century Europe, where the manuscripts first appeared. At the same time, however, as the Arabic reference of the pseudonym suggests, these treatises were clearly products of the medieval Islamic world, including many innovations that would provide the basis for the theory and practice of pharmacy for centuries and arguably formed part of the artisanal epistemological influence on the Scientific Revolution.

[Drugs of a Baroque monastery pharmacy]

This paper deal with a manuscript from the years 1714-1720, originating most probably from the hospital of the Brothers of Mercy in Nové Mesto nad Metují. it contains the records of the hospital pharmacy about the drugs prepared for both patients and monks who operated this hospital. The included drugs were mainly intended for elderly males. The manuscript lists about fifteen hundred drugs and more than three hundred active ingredients, of which about two thirds were of plant origin. The paper presents the compositions of more important drugs and partly deals also with their preparation.

Medicinal use of earths and minerals from Hippocrates to Sir Hans Sloane and beyond

In 1931 two pharmaceutical drawers containing mineral specimens, belonging to Sir Hans Sloane, the 18th century collector, Royal Physician, President of the Royal Society and of the Royal College of Physicians of London, were found in the Department of Botany of the Natural History Museum (NHM) of London. The drawers, each divided into 49 compartments, contained a total of 107 mineral pharmaceutical specimens, some labelled as mercury or white arsenic. Their registration, identification with the Sloane Manuscript Catalogues and subsequent transfer to the Mineralogy department of the NHM where one of these drawers is now on public display, had been documented by 1935. In antiquity therapeutic empiricism attributed medicinal properties to animal products, plants and minerals, including the soil of specific geographic locations. This communication traces the medicinal use of certain earths and minerals, listed in Sir Hans Sloane's manuscript catalogues, to classical antiquity with a reference to Arsenic compounds, which in our time are finding application in the treatment of acute promyelocytic leukaemia and to Terra Lemnia, a celebrated antidote of repute spanning twenty centuries, also included in the Sloane collections.

[A contribution to the development of advertising in pharmacy II. Historical development of regulation of advertising of medicinal products]

The article deals with the development of regulation of advertising of medicinal products in the Czech Lands of the Habsburg Monarchy and Czechoslovakia in the years 1775-1938. Advertising medicines had and has its specifics and its regulation had been addressed by specific standards and linked to other health laws and regulations. Regulation of advertising of medicinal products has undergone a long process from the initial total ban on advertising to the establishment of clear rules, some of which, such as restrictions on advertising prescription-only medicines only to the professional healthcare press, are still valid.

[Our medicinal preparations in the mid-19th century. Part I--Introduction and chemical preparations]

The paper deals with the development of the first editions of the Austrian Pharmacopoeia, Pharmacopoea Austriaca, since its origin in the year 1812. It demonstrates its gradual retardation in the period when nearly all medicinal substances had to be prepared only in pharmacies. The conception was changed as late as 1855 in the Fifth Edition, when it was allowed to buy many medicinal substances from producers or wholesalers. At the same time, requirements for organoleptic properties and chemical purity began to be introduced. The present communication also deals with the chemical drugs used in the mid-19th century and is based on a comparison of the pharmacopoeias of 1836 and 1855. It presents some typical examples, such as alkaloids and metal compounds.

["A" or ... "The" precious manuscript of the "Long life Elixir" just discovered]

This study relates, describes, analyzes & comments the content of a recently discovered old manuscript, written probably at the beginning of the 18th century, and compares it with the well known "Long life Elixir, or Swedish Elixir", manuscript found on a Swedish doctor who died at 104 years old as a result of a fall from his horse... The origin of this new manuscript can be established from 1700 to 1710, and seems to be probably anterior to the well known Swedish manuscript, meanwhile the text is almost similar,... and also is more complete than this one! We learn that the "Manna" is synonymic here of "fine Rhubarb". Another recipe, unknown on the other manuscript and titled "Dalibour Water" is also published: By similar way, this formula brings some new details, in particular in the exact composition, the preparation and the use of the "Long Life Elixir".

[Radium in pharmacy! Second Part: Pharmaceutical used of radium during the inter-war years]

This article presents the raise of patent medicines composed of radium during the inter-war years. Because of a lack of regulation, this production was getting anarchistic. It is studied throught many documents from pharmaceutical laboratories wich are kept by the Curie' museum. Those laboratories would obtain certificates from Curie Institute, to show them in their advertisements.

[From ancient pot collections to the modern medicines. Menier's pot collection-19th century]

At the beginning of the 19th century in 1816, Jean Antoine Brutus Menier founded the "Maison Centrale de Droguerie Menier". It supplied most of the pharmacies in France with drugs of animal, plant and mineral origin for the pharmaceutical preparations recommended at that time. The company provided training for many chemists and pharmacists, and as such, had a collection of pots containing over seven hundred drugs that is currently held at the head office of the Council of the College of Pharmacists in Paris. After having described the pot collection, set it against the 19th century background which experienced a real revolution within this profession, and after retracing its history, a study was then carried out in order to compare the former uses with the modern uses for each of the drugs. Thanks to this detailed, comparative analysis it is now possible to evaluate the relevance of the therapeutic range of drugs in the first half of the 19th century, before the significant rise in chemistry. The Germinal Law changed the pharmacist's profession, and with the birth of chemistry, the art of the pharmacy was revolutionised. However, the drugs, and particularly those of plant origin, have managed to keep a dominant position in today's pharmaceutical domain and in the French or European Pharmacopoeia.

Pharmaceutical high profits: the value of R&D, or oligopolistic rents?

Pharmaceutical firms attribute high prices and high profits to costs associated with researching and developing the next generation of life-saving drugs. Using data from annual reports, this article tests the validity of this claim. We find that while pharmaceutical firms do invest in R&D, they also enjoy strong rents; between 1988 and 2009, pharmaceuticals enjoyed profits of 3 to 37 times the all-industry average, depending on the years, while investing proportionately less in R&D than other high-R&D firms. Costs of pharmaceutical drugs have successfully flown below the radar in much of the current health care debate, with producers managing to obstruct alternative sourcing as well as payment cuts. While health care is examined for savings in other areas, sustained high pharmaceutical profits suggest that as a new health care policy develops in the U.S., the pharmaceutical industry should not be excluded from examination for significant savings in health care costs.

[Evidential research on the first formulas for preparing qiushi (autumn mineral)]

Qiushi is a kind of elixir or medicine. This article examines the books which recorded the formulas for preparing Qiushi. It is found that Liang Fang (Valuable Prescriptions) written by Shen Kuo and Zheng Lei Ben Cao (recognized pharmacopoeia) written by Tang Shengwei recorded the first three formulas. Shen kuo, who recorded two kinds of methods to prepare Qiushi, was neglected by other medical books. The aim of the method to prepare Renzhongbai (natural sediment of urine) was actually to prepare Qiushi.

[The opinion of Herman Boerhaave on medicines, through a non-authorized book]

The treatise of the Virtue of medicines - Herman Boerhaave (1668-1738) was a well known physician from Leiden, who was essentially known in France for the syndrome that received his name and for three of his books, which had been translated in French, and had much success during the 18th century, Elements of Chemistry, Aphorisms and Materia Medica. There was also a fourth book, The Treatise of the Virtue of Medicines, redacted by his students from notes taken during his lessons, which was translated in French in 1729. This volume, in in-8e format, of 471 pages, did not have the same success as his other books. It is anyway very interesting, because it shows that Boerhaave, even if he were Professor of Chemistry was not at all an iatrochemist but behaved as an iatromechanic.

[Radiated drugs, the way of health]

During the inter-war years, the word "radiated" did not only suggest radioactivity, but it was also used to indicate exposure to others radiations, such as ultraviolets. The actinotherapy, a new therapy in vogue, was applied to many pathologies and tried on many substances. "Radiated drugs" result of those experimentations. Their therapeutical characteristics were found during searches on rickets. Our study relates the story of fight against rickets in France, from the use of cod liver oil to the synthesis of Vitamine D.

[Early achievements of the Danish pharmaceutical industry--3. Alfred Benzon]

The article series provides a written and pictorial account of the Danish pharmaceutical industry's products from their introduction until about 1950. Part 3 deals with products from the company founded by Alfred Benzon in 1849. Alfred Nicolai Benzon owned the Swan Pharmacy in Copenhagen. In 1863 he started an independent company manufacturing branded pharmaceuticals, thus combining the pharmacy's activities with the wholesale business. The family owned the company until 1952, when it was converted into a foundation. After several restructuring rounds, the medicine production business continued as Benzon Pharma A/S until 1990, when Nycomed Pharma A/S bought up all the branded pharmaceuticals. As the first pharmaceutical company in Denmark, Alfred Benzon was an industrial frontrunner in the country at the time, supplying not only the domestic market but foreign markets as well. Alfred Benzon was the first Danish company to produce ether for anesthesia, and malt extract, a dietetic preparation. The high quality of both products made them valuable export articles. In the early 1890s, Alfred Benzon became the first Danish company to start the research-based production of extract of thyroid glands from slaughtered cattle. This was the beginning of a long-standing specialization in producing organotherapeutic substances from animal organs originating from Danish animal husbandry. In 1932 the company had 26 preparations of this type in its range, many of them on the market for several years. These medicine substances included iron preparations and effervescent salts followed by sulfonamides, synthetic hormones and a substance to counteract motion sickness.